¼¼¹Ì³ª/Çà»ç

> Á¤º¸¼¾ÅÍ > ¼¼¹Ì³ª/Çà»ç

Á¦¸ñ 2017³â 11¿ù 09ÀÏ »ý¹°Á¤º¸ÇÐ ¼¼¹Ì³ª
ÀÛ¼ºÀÚ °ü¸®ÀÚ ÀÛ¼ºÀÏ 2017-11-06

¼­¿ï´ëÇб³ »ý¹°Á¤º¸¿¬±¸¼Ò¿Í »ý¹°Á¤º¸ÇÐ Çùµ¿°úÁ¤ °øµ¿ ÁÖÃÖ·Î ¼¼¹Ì³ª¸¦ ¾Æ·¡¿Í °°ÀÌ ¿­°íÀÚ ÇÏ¿À´Ï, ¸¹Àº Âü¿© ¹Ù¶ø´Ï´Ù.

¡¡

ÀϽÃ: 2017³â 11¿ù 09ÀÏ ¸ñ¿äÀÏ ¿ÀÀü 11½Ã

¿¬»ç: °í±¤Ç¥ (¼­¿ï´ëÇб³ º¸°Ç´ëÇпø)

Àå¼Ò: ¼­¿ï´ëÇб³ 25µ¿ 411È£

¡¡

Title : Genomics Approach for Microbiome Therapeutics

Abstract : There were dramatically increased interests on human microbiome research worldwide. While human ecosystems is maintained through mutualistic relationship between host and microbiota, human microbiota is certainly to play a crucial role in development and function of the immune system. Recent advances in metagenomics and metabolomics techniques provide the enormous amount of evidences of specific microorganisms and their functions for controlling the host immune and metabolic status. Particularly, a number of recent studies indicated that gut microbiota and their metabolites play an important role in educating and modulating the host immune system. Currently, a number of research groups are vigorously investigating to identify the etiological agents of microorganisms and their metabolites for various diseases and to develop the novel drugs using these substances. This talk will help to understand the current status and predict the future application of microbiome therapeutics.

¡¡

Education

±â°£

Çб³

Àü°ø

ÇÐÀ§

1996³â 9¿ù - 2000³â 5¿ù

Harvard University

º¸°Ç ¹Ì»ý¹°ÇÐ

¹Ú»ç

1992³â 3¿ù - 1994³â 2¿ù

¼­¿ï´ëÇб³

ºÐÀÚ ¹ÙÀÌ·¯½ºÇÐ

¼®»ç

1988³â 3¿ù - 1992³â 2¿ù

¼­¿ï´ëÇб³

¹Ì»ý¹°ÇÐ

Çлç

¡¡

Experience

±â°£

Çб³

Á÷À§

2012³â 9¿ù ÇöÀç

¼­¿ï´ëÇб³ º¸°Ç´ëÇпø

Á¤±³¼ö

2003³â 6¿ù 2005³â 8¿ù

University of Texas Health Science Center at Houston

Á¶±³¼ö

2001¿ù 6¿ù 2003³â 5¿ù

University of NorthCarolina at ChapelHill

¹Ú»ç ÈÄ ¿¬±¸¿ø

¡¡

Selected Publications

1. Si J, You HJ, Sung J, and Ko G*. 2017. Prevotella as a hub for vaginal microbiota under the influence of host genetics and their association with obesity. Cell Host Microbe. 21(1):97-105.

2. Lim MY, You HJ, Yoon HS, Kwon B, Lee KY, Lee S, Song YM, Sung J, Ko G*. 2017. The effect of heritability and host genetics on the gut microbiota and metabolic syndrome. Gut, Apr 6, 2015-311326

3. Lee H and Ko G*, 2016, Antiviral effect of vitamin A on norovirus infection via modulation of the gut microbiome, Sci. Rep. 16:6:25835

4. Lim MY, You HS, Rho M, Sung J, Lee K, Ko G*. 2016. Analysis of the association between host genetics, smoking, and sputum microbiota in healthy humans. Sci. Rep., 31:6:23745

5. Yassour M, Lim My, Yun HS, Tickie TL, Sung J, Song YM, Lee K, Franzosa EA, Morgan XC, Gevers D, Landers ES, Xavier RJ, Birren BW, Ko G, and Huttenhower G, 2016, Subclinical detection of gut microbial biomarkers of obesity and type 2 diabetes, Genome Med, 17(8):17

6. Si J, Lee S, Park JM, Sung J, and Ko G*. 2015. Genetic associations and shard environmental effects on the skin microbiome of Korean twins. BMC Genomics, 23:16:992.

7. Lee S, Cantarel B, Henrissat B, Gevers D, Birren BW, Huttenhower C, Ko G*. 2014. Gene-targeted metagenomic analysis of glucan-branching enzyme gene profiles among human and animal fecal microbiota. ISME J. 8:493-503.

8. Lim MY, Rho M, Song YM, Lee KY, Sung J, Ko G*. 2014. Stability of gut enterotypes in Korean monozygotic twins and their association with biomarkers and diet. Sci. Rep. 8:4:7328.

9. Lee H, Ko G*. 2014. Effect of metformin on metabolic improvement and gut microbiota. Appl Environ Microbiol. 80:5935-5943.

¡¡

¼­¿ï´ëÇб³ »ý¹°Á¤º¸¿¬±¸¼Ò¡¤»ý¹°Á¤º¸ÇÐ Çùµ¿°úÁ¤ °øµ¿ÁÖÃÖ